Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study Using Thalidomide for the Treatment of Amyotrophic Lateral Sclerosis

NCT00140452 is registered in ClinicalTrials.gov with Dartmouth-Hitchcock Medical Center as lead sponsor.

NCT NCT00140452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00140452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study Using Thalidomide for the Treatment of Amyotrophic Lateral Sclerosis
Lead sponsor
Dartmouth-Hitchcock Medical Center
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2005
Completion date
November 30, 2007
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

als, amyotrophic lateral sclerosis